Lab members


Peter D. Adams, PhD –

Peter Adams obtained his BA in biochemistry at the University of Oxford, England and his PhD at Imperial Cancer Research Fund (now CR-UK). He did post-doctoral work with Dr. William G. Kaelin, Jr. at Dana-Farber Cancer Institute. He set up his own lab at Fox Chase Cancer Center in 1999 and moved to the CR-UK Beatson Institute and Glasgow University in October of 2008. In December 2016, Peter relocated primarily to Sanford Burnham Prebys Medical Discovery Institute in San Diego, California; although the lab is currently also still active in Glasgow, Scotland. Peter Adams is co-Editor-in-Chief of the journal Aging Cell. 

The lab in San Diego, California at Sanford Burnham Prebys Medical Discovery Institute :

Aaron Havas, PhD


Aaron obtained his PhD in Cancer Biology from the University of Arizona in December 2016 where he determined the molecular mechanisms of resistance to histone deacetylase inhibitors in Diffuse large B-cell lymphoma. Aaron then joined Peter Adams’ lab in February 2017, where he is focusing on understanding the epigenetic drivers of aging and the development of age-related diseases in the liver. To assess this, he is using a number of mouse models and single cell technologies in order to gain a better understanding at an individual cellular resolution.


Andrew Davis, BSc

AndrewAndrew is the Laboratory Technician in the Adams lab in San Diego. He is originally from Ventura, Ca, and went to college in San Diego where he graduated from UCSD with a B.S. in Biochemistry and Cell Biology. He has been interested in science from a very young age, and is happy to be continuing in his scientific career. Alongside his interest in the rigor and discovery of science, he has made a hobby of math, computers, and 3D printing. 



Nirmalya Dasgupta, PhD


Nirmalya obtained his BSc (Hons) in Chemistry and MSc in Biochemistry from the University of Calcutta, India, before joining the R&D division of a renowned pharmaceutical company in India as a Biological Chemist. He spent more than four years in the pharmaceutical industry before returning to academia and obtaining his PhD from the department of Biochemistry at the University of Calcutta, where he studied the transcriptional regulation of differentiation-induced genes in intestinal epithelial cells. In 2017, Nirmalya joined the Adams laboratory as a post-doc, where he is studying the epigenetics of senescence, the hallmark of the aging cell. His work aims to uncover how inflammation is generated during aging, with the ultimate goal of discovering novel therapeutic interventions which reduce inflammation in aging tissues.  In his free time, Nirmalya is passionate about swimming and Himalayan hiking to altitudes of 12-19,000 feet, and is interested in Buddhism, history and politics.  

Ying Wang, PhD

Adam Field, BSc.

Adam_FieldAdam obtained his BSc (Hons) in Biomedical Sciences from Newcastle University, specialising in ageing and cancer. His dissertation investigated DNA methylation patterns in adult leukaemia under the supervision of Dr Gordon Strathdee at The Northern Institute for Cancer Research. Graduating in 2013, he then spent two years in AstraZeneca’s Disease Biology group conducting high throughput screening for effective combination therapies against a range of cancer targets. His current area of research focuses on the epigenetic effects of rapamycin in ageing and cancer. 


The lab in Glasgow, Scotland at Beatson Institute for Cancer Research and University of Glasgow :

Claire Brock, BSc. –

Claire Brock obtained her BSc from the University of Glasgow. 

Farah Jaber-Hijazi, PhD. –

Farah Jaber-Hijazi obtained her MSc at the Universities of Manchester, Salford and Keele and her PhD from the University of Nottingham. 

Maria Grazia Vizioli, PhD. –

Maria Grazia Vizioli obtained her PhD from The Open University, UK. 

Arantxa Perez, PhD.



Arantxa obtained her BSc in Biology from the Universidad de Valencia, and her PhD in Molecular Biology from the Universidad Autonoma de Madrid. 



Neil Robertson, BSc. –

Neil Robertson obtained his BSc from University of Glasgow

Kathryn Gilroy, PhD. 

Profile picKathryn obtained her BSc. in Biochemistry from the University of York. During this time, she spent 12 months at Novartis Pharma screening compounds for potential drug-drug interactions. She then obtained her PhD in Biomedical Science from Newcastle University, where she studied the structure and mechanism of human topoisomerase II isoforms under the supervision of Prof. Caroline Austin. Following post-doctoral positions in proteomics and molecular oncology at the University of Glasgow, she now works as a computational biologist for the Adams group. Her work focuses on methylation patterns at regulatory elements in human cancer and how this relates to ageing.

Francisco Marques, PhD. –

Francisco Marques obtained his PhD from the University of Newcastle. 

Ashley Newcombe, BSc. –

Ashley is currently a PhD student at Glasgow University, UK.


Dr. Rugang Zhang – former post 2003-2008; now Associate Professor, Wistar Institute, Philadelphia.
Dr. Andres Ivanov – former post doc 2008-2012; now Lecturer in Haemato-Oncology, Barts Cancer Institute, London.
Dr. Taranjit Singh Rai – former post doc 2008-2014; now Lecturer University of West of Scotland.
Dr. Alyssa Kennedy – former M.D. PhD student 2006-2011; now Senior Resident, Children’s Hospital, Boston.


%d bloggers like this: